Violation of drug price control order: Drug cos under NPPA lens for self-exemption from price capPricing watchdog has found that companies such as Lupin and Boehringer Ingelheim launched products bypassing the regulatory framework. The ...
16 Dec, 2019, 08.31 PM IST
Supreme Court prescribes pain relief for 15 banned combination drugsThe order effectively brings several popular cough syrups, painkillers and cold medication out of the health ministry’s impending ban list,...
08 Sep, 2018, 06.43 AM IST
Havas Group acquires healthcare agency SorentoSorento will partner with 'Havas Health and You' business unit and be rebranded Havas Life Sorento, the agency said in a statement.
25 May, 2017, 03.37 PM IST
IIT Bombay’s Shailesh J. Mehta School of Management completes final placementsDespite a 50% increase in batch strength, the average CTC increased to Rs 16.5 lakh this time from last year’s average of Rs 16.2 lakh.
27 May, 2016, 02.09 PM IST
HC to resume hearing on pharma cos' pleas against Centre's orderThe companies have contended that the decision was taken by the government without issuing them a show cause notice or granting them a hear...
20 Mar, 2016, 11.50 AM IST
Centre ban on FDCs: Procter and Gamble, Glenmark, Reckitt Benckiser too get Delhi High Court reliefAs a result of the court's order, the ban on sale of P&G's Vicks Action 500 extra, Reckitt's D'Cold and Piramal's Saridon have been lifted ...
16 Mar, 2016, 07.14 PM IST
Drug ban: Pharma market to see immediate loss of Rs 1,000 croreTaking the drug industry by surprise, the health ministry, in a notification issued on March 12, prohibited the manufacture, sale and distr...
16 Mar, 2016, 12.23 PM IST
Glenmark Pharma wins patent suit against Abbott; stock gainsGlenmark Pharamceuticals had filed a pre-grant opposition in September 2008 after Abott was granted a patent to Humira drug.
08 Jan, 2015, 10.13 AM IST
Glenmark Pharma Q4 net profit at Rs 43 croreConsolidated net sales of the company rose to Rs 1,681.74 crore for the fourth quarter, as against Rs 1,335.48 crore in the same period of ...
08 May, 2014, 06.35 PM IST
Glenmark under pressure after losing patent battle to AbbottShares of Glenmark Pharmaceuticals saw profit booking after the company announced that it has lost appeal to invalidate Abbott's patent for...
22 Apr, 2014, 04.05 PM IST
- Glenmark hit by adverse verdict
Glenmark Pharma's stock slid by 11% in the past two trading sessions due to an unfavourable jury verdict in a patent litigation.
19 Jan, 2011, 02.38 AM IST
- Glenmark Pharma tanks 7 pc on BSE
Extending its losses for the fifth day today, Glenmark Pharmaceuticals fell sharply by 7 per cent in early trade on the Bombay Stock Exchan...
18 Jan, 2011, 11.38 AM IST
- Glenmark loses patent case to Abbott over hypertension drug
Glenmark has lost a patent case against US firm Abbott Laboratories over hypertension drug Tarka.
15 Jan, 2011, 07.08 PM IST
- Glenmark scores over Sanofi, Abbott in US patent challenge
Glenmark Pharmaceutical has scored in its patent tussle with Sanofi Aventis and Abbott after the New Jersey district court upheld the chall...
09 Jun, 2010, 01.42 AM IST
- Glenmark confirms Abbott suit against Tarka generic
Glenmark Pharmaceuticals has confirmed that Abbott has filed a suit in the US District Court of New Jersey on December 7, seeking to preven...
13 Dec, 2007, 10.13 AM IST
- Sanofi, Abbott file lawsuit against Glenmark
Sanofi-Aventis SA and Abbott Laboratories have jointly filed a lawsuit against Glenmark to prevent the Indian company from selling its hype...
13 Dec, 2007, 01.51 AM IST
- Wockhardt challenges patents litigation
Wockhardt Pharma has just got into the game. The co is challenging Abbott Lab patent on epilepsy drug.
25 May, 2007, 02.30 AM IST